Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Dale

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|September 25, 2018
Caution Indicated in Extrapolating Carditis in Rats to Rheumatic Heart Disease in HumansJames B Dale, Stanford T Shulman
Molecular Microbiology|January 20, 2006
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related proteinHarry S Courtney, David L Hasty, James B Dale
Annals of Medicine|July 11, 2002
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococciHarry S Courtney, David L Hasty, James B Dale
Current Microbiology|March 23, 2002
Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococciHarry S Courtney, James B Dale, David L Hasty
Infection and Immunity|August 23, 2003
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococciHarry S Courtney, David L Hasty, James B Dale
The Pediatric Infectious Disease Journal|January 19, 2013
Progress toward a global group a streptococcal vaccineAndrew C Steer, James B Dale, Jonathan R Carapetis
Msphere|December 21, 2018
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <i>Streptococcus pyogenes</i>Sanaz Salehi, Claudia M Hohn, Thomas A Penfound, et al.
Vaccine|June 16, 2010
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopesThomas A Penfound, Edna Y Chiang, Elwaleed A Ahmed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshopAlan L Bisno, Fran A Rubin, P Patrick Cleary, et al.
Vaccine|September 17, 2011
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciJames B Dale, Thomas A Penfound, Edna Y Chiang, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|September 25, 2018
Caution Indicated in Extrapolating Carditis in Rats to Rheumatic Heart Disease in HumansJames B Dale, Stanford T Shulman
Molecular Microbiology|January 20, 2006
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related proteinHarry S Courtney, David L Hasty, James B Dale
Annals of Medicine|July 11, 2002
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococciHarry S Courtney, David L Hasty, James B Dale
Current Microbiology|March 23, 2002
Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococciHarry S Courtney, James B Dale, David L Hasty
Infection and Immunity|August 23, 2003
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococciHarry S Courtney, David L Hasty, James B Dale
The Pediatric Infectious Disease Journal|January 19, 2013
Progress toward a global group a streptococcal vaccineAndrew C Steer, James B Dale, Jonathan R Carapetis
Msphere|December 21, 2018
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <i>Streptococcus pyogenes</i>Sanaz Salehi, Claudia M Hohn, Thomas A Penfound, et al.
Vaccine|June 16, 2010
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopesThomas A Penfound, Edna Y Chiang, Elwaleed A Ahmed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshopAlan L Bisno, Fran A Rubin, P Patrick Cleary, et al.
Vaccine|September 17, 2011
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciJames B Dale, Thomas A Penfound, Edna Y Chiang, et al.
Pageof 7